Dacarbazine and fotemustine in advanced colorectal cancer-Reference-Cited by-同舟云学术

Dacarbazine and fotemustine in advanced colorectal cancer

Published:1993-01 Issue:3 Volume:29 Page:476
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Tixi L.,Bolli E.,Guglielmi A.,Mori A.,Aschele C.,Nobile M.T.,Rosso R.,Sobrero A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference10 articles.

1. Biochemical modulation: a modality that has come of therapeutic age;Allegra;J Clin Oncol,1991

2. Systemic therapy in metastatic colorectal cancer;Hansen;Arch Intern Med,1990

3. Phase II trial of fotemustine in advanced colorectal cancer;Bleiberg;Eur J Cancer,1990

4. Multicentric study of the nitrosourea fotemustine (S 10036) in advanced malignant melanoma (AMM) including patients with cerebral metastases;Jacquillat,1988

5. Radiation therapy (RT) plus concomitant fotemustine for brain metastasis from non small cell lung cancer (NSCLC);Pignon,1992

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laparoscopic ovarian transposition before pelvic radiation in rectal cancer patient: safety and feasibility;Annals of Surgical Innovation and Research;2012-09-17

2. Neo-adjuvant Therapy;Modern Management of Cancer of the Rectum;2001

3. Adjuvant combined modality therapy for rectal cancer;Cancer Treatment and Research;1998

4. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer;Diseases of the Colon & Rectum;1997-05

5. Ondansetron for the control of dacarbazine-induced emesis;European Journal of Cancer;1995-09